Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 2
1992 4
1993 1
1994 4
1996 1
1997 2
1998 3
1999 1
2000 2
2001 4
2002 3
2003 2
2004 7
2005 7
2006 8
2007 9
2008 7
2009 6
2010 2
2011 1
2012 6
2013 3
2014 6
2015 2
2016 1
2017 1
2018 1
2019 2
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

93 results
Results by year
Filters applied: . Clear all
Page 1
The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats.
Steven S, Oelze M, Hanf A, Kröller-Schön S, Kashani F, Roohani S, Welschof P, Kopp M, Gödtel-Armbrust U, Xia N, Li H, Schulz E, Lackner KJ, Wojnowski L, Bottari SP, Wenzel P, Mayoux E, Münzel T, Daiber A. Steven S, et al. Redox Biol. 2017 Oct;13:370-385. doi: 10.1016/j.redox.2017.06.009. Epub 2017 Jun 22. Redox Biol. 2017. PMID: 28667906 Free PMC article.
TAF-ChIP: an ultra-low input approach for genome-wide chromatin immunoprecipitation assay.
Akhtar J, More P, Albrecht S, Marini F, Kaiser W, Kulkarni A, Wojnowski L, Fontaine JF, Andrade-Navarro MA, Silies M, Berger C. Akhtar J, et al. Life Sci Alliance. 2019 Jul 22;2(4):e201900318. doi: 10.26508/lsa.201900318. Print 2019 Aug. Life Sci Alliance. 2019. PMID: 31331983 Free PMC article.
Drivers of topoisomerase II poisoning mimic and complement cytotoxicity in AML cells.
More P, Goedtel-Armbrust U, Shah V, Mathaes M, Kindler T, Andrade-Navarro MA, Wojnowski L. More P, et al. Oncotarget. 2019 Sep 3;10(51):5298-5312. doi: 10.18632/oncotarget.27112. eCollection 2019 Sep 3. Oncotarget. 2019. PMID: 31523390 Free PMC article.
[Chemotherapeutics-induced heart failure].
Paulides M, Wojnowski L. Paulides M, et al. Med Klin (Munich). 2007 Jul 15;102(7):574-8. doi: 10.1007/s00063-007-1071-y. Med Klin (Munich). 2007. PMID: 17634876 Review. German.
Genotyping the risk of anthracycline-induced cardiotoxicity.
Deng S, Wojnowski L. Deng S, et al. Cardiovasc Toxicol. 2007;7(2):129-34. doi: 10.1007/s12012-007-0024-2. Cardiovasc Toxicol. 2007. PMID: 17652817 Review.
Clinical implications of CYP3A polymorphisms.
Wojnowski L, Kamdem LK. Wojnowski L, et al. Expert Opin Drug Metab Toxicol. 2006 Apr;2(2):171-82. doi: 10.1517/17425255.2.2.171. Expert Opin Drug Metab Toxicol. 2006. PMID: 16866606 Review.
Cytochrome P450 3A and their regulation.
Burk O, Wojnowski L. Burk O, et al. Naunyn Schmiedebergs Arch Pharmacol. 2004 Jan;369(1):105-24. doi: 10.1007/s00210-003-0815-3. Epub 2003 Oct 21. Naunyn Schmiedebergs Arch Pharmacol. 2004. PMID: 14569421 Review.
Health-Relevant Phenotypes in the Offspring of Mice Given CAR Activators Prior to Pregnancy.
Dietrich K, Baumgart J, Eshkind L, Reuter L, Gödtel-Armbrust U, Butt E, Musheev M, Marini F, More P, Grosser T, Niehrs C, Wojnowski L, Mathäs M. Dietrich K, et al. Drug Metab Dispos. 2018 Nov;46(11):1827-1835. doi: 10.1124/dmd.118.082925. Epub 2018 Aug 28. Drug Metab Dispos. 2018. PMID: 30154105
Genetics of the variable expression of CYP3A in humans.
Wojnowski L. Wojnowski L. Ther Drug Monit. 2004 Apr;26(2):192-9. doi: 10.1097/00007691-200404000-00019. Ther Drug Monit. 2004. PMID: 15228164 Review.
Dexrazoxane may prevent doxorubicin-induced DNA damage via depleting both topoisomerase II isoforms.
Deng S, Yan T, Jendrny C, Nemecek A, Vincetic M, Gödtel-Armbrust U, Wojnowski L. Deng S, et al. BMC Cancer. 2014 Nov 18;14:842. doi: 10.1186/1471-2407-14-842. BMC Cancer. 2014. PMID: 25406834 Free PMC article.
93 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback